Fluorescein angiography, optical coherence tomography, and histopathologic findings in a VEGF165 animal model of retinal angiogenesis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 10, 2012, Pages 1421-1428

  Arana, Luís A ^a,b   Pinto, Anderson T ^a,c   Chader, Gerald J ^a   Barbosa, Jose D ^a   Morales, Sabina ^a   Moreira, Ana T ^b   Maia, Mauricio ^c   Humayun, Mark S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Animal model; Fluorescein angiography; OCT; Retinal neovascularization; VEGF

Indexed keywords

VASCULOTROPIN 165;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; BLOOD VESSEL SHUNT; CONTROLLED STUDY; ENUCLEATION; EXPERIMENTAL RABBIT; FOLLOW UP; HISTOPATHOLOGY; MOLECULAR PATHOLOGY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; RETINAL THICKNESS; VISUAL SYSTEM PARAMETERS;

ANIMALS; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; RABBITS; RECOMBINANT PROTEINS; RETINAL DETACHMENT; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867713247     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-1978-8     Document Type: Article

References (34)

1. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J, Congdon N (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564-572
2. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF, Eye Diseases Prevalence Research Group (2004) The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122:552-563
3. Aiello LP, Avery RL, Arrigg PG, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487
4. Wells JA, Murthy R, Chibber R, Nunn A, Molinatti PA, Kohner EM, Gregor ZJ (1996) Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Br J Ophthalmol 80:363-366
5. Galan A, Ferlin A, Caretti L, Buson G, Sato G, Frigo AC, Foresta C (2010) Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. Ophthalmology 117:1769-1774
6. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32
7. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, Plouet J (1995) Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 164:385-394
8. Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211-220
9. Park JE, Keller GA, Ferrara N (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326
10. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura Y, Hida T, Oguchi Y, Ambati J, Miller JW, Gragoudas ES, Ng YS, D'Amore PA, Shima DT, Adamis AP (2003) VEGF164-mediated inflammation is required for pathological, but not physiological, ischemiainduced retinal neovascularization. J Exp Med 198:483-489
11. Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP (2003) VEGF 164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44:2155-2162
12. Sampaio RB, Mendonca RJ, Simioni AR, Costa RA, Siqueira RC, Correa VM, Tedesco AC, Haddad A, Coutinho Netto J, Jorge R (2010) Rabbit retinal neovascularization induced by latex angiogenic-derived fraction: an experimental model. Curr Eye Res 35:56-62
13. Tano Y, Chandler DB,Machemer R (1981) Retinal neovascularization after intravitreal fibroblast injection. Am J Ophthalmol 92:103-109
14. Saati S, Agrawal RN, Louie S, Chader GJ, Humayun MS (2010) Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits. Graefes Arch Clin Exp Ophthalmol 248:457-466
15. Wong CG, Rich KA, Liaw LH, Hsu HT, Berns MW (2001) Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Curr Eye Res 22:140-147
16. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, Oshima K (1997) Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of blood-retinal barrier in rabbits and primates. Exp Eye Res 64:505-517
17. Deem CW, Futterman S, Kalina RE (1974) Induction of endothelial cell proliferation in rat retinal venules by chemical and indirect physical trauma. Invest Ophthalmol 13:580-585
18. Hamilton AM, Marshall J, Kohner EM, Bowbyes JA (1975) Retinal new vessel formation following experimental vein occlusion. Exp Eye Res 20:493-497
19. Tamura M (2001) Neovascularization in experimental retinal venous obstruction in rabbits. Jpn J Ophthalmol 45:144-150
20. Pournaras CJ, TsacopoulosM, Strommer K, Gilodi N, Leunenberger PM (1990) Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology 97:1321-1328
21. Finkelstein D, Brem S, Patz A, Folkman J, Miller S, Ho-Chen C (1977) Experimental retinal neovascularization induced by intravitreal tumors. Am J Ophthalmol 83:660-664
22. Penn JS, Tolman BL, Lowery LA (1993) Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci 34:576-585
23. Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18:502-508
24. Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902-916
25. Ameri H, Chader GJ, Kim JG, Sadda SR, Rao NA, Humayun M (2007) The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci 48:5708-5715
26. Alikacem N, Yoshizawa T, Nelson KD, Wilson CA (2000) Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits. Invest Ophthalmol Vis Sci 41:1561-1569
27. Sato T, Kusaka S, Shimojo H, Fujikado T (2009) Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology 116:2165-2169
28. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905-909
29. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, La Rochele W, Zack DJ, Campochiaro PA (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281-291
30. Suto C, Kitano S, Hori S (1992) An experimental model of intravitreal neovascularization in rabbits [Japanese]. Nihon Ganka Gakkai Zasshi 96:959-966
31. Pournaras CJ, Rungger-Brändle E, Riva CE, Hardarson SH, Stefansson E (2008) Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27:284-330
32. Hofman P, van Blijswijk BC, Gaillard PJ, Vrensen GF, Schlingermann RO (2001) Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch Ophthalmol 119:861-866
33. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820-1828
34. McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen HP, Wong TY (2010) Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117:1113-1123